Abstract. Objective. A common orthopaedic pain found in a wide spectrum of individuals, from young and active to the elderly is anterior knee pain (AKP). It is a multifactorial disorder which is thought to occur through muscular imbalance, overuse, trauma, and structural malalignment. Over time, this can result in cartilage damage and subsequent chondral lesions. Whilst the current gold standard for chondral lesion detection is MRI, it is not a highly sensitive tool, with around 20% of lesions thought to be mis-diagnosed by MRI. Single-photon emission computerised tomography with conventional computer tomography (SPECT/CT) is an emerging technology, which may hold clinical value for the detection of chondral lesions. SPECT/CT may provide valuable diagnostic information for AKP patients who demonstrate absence of structural change on other imaging modalities. This review systematically assessed the value of SPECT/CT as an imaging modality for knee pain, and its ability to diagnose chondral lesions for patients who present with knee pain. Methods. Using PRISMA guidelines, a systematic search was carried out in PubMed, Science Direct, and Web of Knowledge, CINAHL, AMED, Ovid Emcare and Embase. Inclusion criteria consisted of any English language article focusing on the diagnostic value of SPECT/CT for knee chondral lesions and knee pain. Furthermore, animal or cadaver studies, comparator technique other than SPECT/CT or patients with a pathology other than knee chondral lesions were excluded from the study. Relevant articles underwent QUADAS-2 bias assessment. Results. 11,982 manuscripts were identified, and the titles were screened for relevance. Seven studies were selected as being appropriate and were subjected to QUADAS-2 assessment. All 7 articles scored low for bias. Two papers deemed that the ICRS score of chondral lesions at intraoperative assessment correlated with SPECT/CT tracer uptake. Two studies concluded that MRI significantly correlated with SPECT/CT tracer uptake, with some instances whereby SPECT/CT identified more chondral lesions than MRI. Two papers compared bone scintigraphy (BS) to SPECT/CT and concluded that SPECT/CT was not only able to identify more chondral lesions than BS, but also localise and characterise the lesions. Conclusion. Evidence implies that SPECT/CT may be a useful imaging modality for the detection and localisation of cartilage lesions, particularly in discrepant cases whereby there is an absence of lesions on other imaging modalities, or a lack of correspondence with patients’ symptoms. More studies would be of value to confirm the conclusions of this review. Declaration of Interest. (b) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported:I declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project

Aim. Septic arthritis (SA) is considered a medical emergency. The most common etiological agents are glucose consuming bacteria, so we evaluated the clinical utility of synovial fluid (SF) glucose levels and other biochemical parameters for supporting the diagnosis of the disease and their association with a positive bacteria culture and joint destruction. Methods. Adult patients with SA diagnose were enrolled prospectively between July 2018 and October 2019. As control group, adults with knee osteoarthritis, meniscus and/or knee ligaments lesions were enrolled. SF samples were obtained from the joints by arthrocentesis/arthrotomy. Microbiological analyses of SF were performed using Brucella broth blood culture flasks, samples were incubated at 37°C with 5% CO. 2. for 24 hours. Gram stain, chocolate and blood agar were used for the identification and growth of the bacteria. SF glucose levels, pH and leukocyte esterase were measured as biochemical parameters using a glucometer and colorimetric test strips. The Outerbridge classification was used for grading the osteochondral injury. Furthermore, blood samples were collected from patients and control subjects for determining glucose levels. Results. We included 8 subjects with knee ligaments lesions, 6 with meniscus lesions and 5 with osteoarthritis as control group, as well as 20 patients with SA diagnose. The mean age of the patients was 57.8 years with a 65% of male predominance. The most common affected joint was the knee (85%). SF culture was positive in 60% of the cases and the most common etiological agent was Staphylococcus aureus (58.3%). SF glucose levels from patients were lower than the controls (P=0.0018) and showed the lowest concentration in patients with a positive culture (P=0.0004). There was also a difference between blood and SF glucose concentration from the positive culture patients (P<0.0001). Leucocyte esterase presented the highest values in positive culture patients (P=<0.0001) and a more acidic pH was found compared to the control group (P<0.0001). Regarding the osteochondral injury, the lowest concentrations of SF glucose were found in patients with a higher grade in the classification (P = 0.0046). Conclusions. SF glucose and leukocyte esterase concentrations might be a quick and cheap useful parameter for the physician for distinguishing between bacterial infection and not infected joint. In addition, the lowest SF glucose levels might give information about the joint damage due to the disease

Aims

Osteochondral lesions of the talus (OLT) are a common cause of disability and chronic ankle pain. Many operative treatment strategies have been introduced; however, they have their own disadvantages. Recently lesion repair using autologous cartilage chip has emerged therefore we investigated the efficacy of particulated autologous cartilage transplantation (PACT) in OLT.

Osteoarthritis is a slowly progressive disease which includes the intervention of several cytokines and macrophage metalleinoproteinases reaction, leading to the degradation of the local cartilage but also having an impact on the serum acute phase proteins (APPs). Subsequently, biomarkers seem to be essential to estimate its progression and the need for any surgical intervention such as total arthroplasty, but also can be used as therapeutic agents. Recently, among APPs, fetuin-A drew attention regarding its possible anti-inflammatory role in animal models but also as a therapeutic agent in the inflammatory joint disease in clinical trials. The purpose of this study is to investigate the possible attenuating role of the intra-articular administration of Fetuin-A in post-traumatic induced secondary osteoarthritis in rats, and also its effect on the systematic levels of IL-2,4,7, BMPs 2,4,7, CRP and Fetuin-A. 30 male Sprague Dawley rats were separated in two groups where post-traumatic osteoarthritis was induced surgically by Anterior Cruciate Ligament Transection and the transection of the Medial Collateral Ligament of the right knee. In the Control Group, only surgical intervention took place. In Fetuin Group, along with the induction of osteoarthritis, a single dose of bovine fetuin was administrated intra-articularly intra-operatively in 5 and 8 weeks of the experimental protocol. Both groups were examined for 8 weeks. The levels of interleukins, bone morphogenetic proteins, Fetuin-A and C-Reactive Protein were evaluated by ELISA of peripheral blood in three time periods: preoperatively, 5 and 8 weeks post-operatively. Knee osteoarthritic lesions were classified according to Osteoarthritis Research Society International Grading System and Modified Mankin Score, by histologic examination. IL-2 levels were significantly decreased in the Fetuin Group. No statistical difference was signed on the levels of IL-7, BMP-2,4,7 and Fetuin-A between the two groups. CRP levels were significantly increased in the Fetuin Group in 5 weeks of the experiment. Fetuin Group signed better scores according to the OARSI classification system and Modified Mankin Score, without any statistical significance. Intra-articular administration of Fetuin-A restrictively affected the progression of post-traumatic arthritis in rats, as only the levels of IL-2 were decreased as well as limited osteoarthritic lesions were observed on the Fetuin Group

Aims

To explore the efficacy of extracorporeal shockwave therapy (ESWT) in the treatment of osteochondral defect (OCD), and its effects on the levels of transforming growth factor (TGF)-β, bone morphogenetic protein (BMP)-2, -3, -4, -5, and -7 in terms of cartilage and bone regeneration.

The December 2012 Knee Roundup. 360. looks at: the demand for knee replacement; a Japanese knee outcome score; smoking and TKR; coronal alignment as a determinant of outcome in TKR; fixed flexion; MRI detected knee lesions; and lateral domed Oxford unicompartmental knee replacements

Introduction MRI accuracy in detecting knee lesions is a discussed controversy. Not always different knee lesions, diagnosed by MRI are confirmed by arthroscopy. The aim of this study is to correlate the accuracy of history, physical examination and MRI in evaluating meniscal and ACL lesions. Methods A prospective comparative study was performed to compare anamnestic and clinical data, MRI findings and arthroscopic findings to better understand the role of these methods and to assess if there are significative differences between various knee disorders. One hundred patients undergoing to arthroscopy for knee injuries were evaluated before surgery, registering anamnestic data, clinical examination and MRI findings. At the time of surgery every finding was registered and then compared with the previous acquired data. Results The most accurate data for diagnosis appears from history and clinical examination. The study showed a statistically significative differences between the RMI and arthroscopic findings. Differences between radiologist were detected in MRI data. Conclusion The results of such type of study, underlining the reliability and accuracy of patient’s history, clinical examination and MRI, comparing the different results among them and in various knee injuries. The accuracy of every test is the first step for an evidence based decision analysis process and represent a step forward an efficacious and economical pattern in diagnosis

Aims

Tert-butylhydroquinone (tBHQ) has been identified as an inhibitor of oxidative stress-induced injury and apoptosis in human neural stem cells. However, the role of tBHQ in osteoarthritis (OA) is unclear. This study was carried out to investigate the role of tBHQ in OA.

Background:. Different surgical approaches have been proposed for the treatment of chondral lesions. However surgical management of osteochondral defects of the knee joint involving subchondral bone are still under debate. Purpose:. The aim of this prospective non-randomized uncontrolled clinical investigation is to confirm the effectiveness of a commercially available biomimetic osteochondral scaffold in regenerating cartilage and subchondral bone of severe osteochondral lesions of the knee joint with one step surgery. Methods:. The biomimetic scaffold has a multilayer structure consisting of a combination of type I collagen and type I collagen/hydroxyapatite, mimicking the osteochondral connective tissue of the knee joint. From 2009 to 2011, sixty-one patients affected by grade III or IV osteochondral lesions of the knee, according to Outerbridge Classification, were admitted to three centers and received the biomimetic scaffold. Four-nine patients were evaluated using the International Knee Documentation Committee (IKDC), Tegner and VAS scores, and MRI at 1-, 2- and 3-year follow-ups. Biopsies were carried out in 5 patients at an average time of 19.2 months to histologically evaluate the quality of the newly-formed tissue. Results:. All patients tolerated the surgery well; no major adverse events were observed in the early postoperative period. Clinical evaluation of the 49 patients showed a statistically significant improvement in all scores at 1- 2- and 3-year follow-ups as compared to preoperative baseline scores. Improvement in the scores and functional recovery seemed to reach a plateau after 2 years; no significant improvement was seen between the 2- and the 3-year follow-up. Conclusions:. A synthetic biomimetic scaffold used in one-step surgery for the treatment of severe osteochondral knee lesions significantly improved symptoms and joint function, as demonstrated by subjective and objective scoring system evaluation. Furthermore, the athletic subpopulation exhibited a significantly better outcome than the non-athletic subpopulation

Autologous chondrocyte transplantation has become a possible solution for the treatment of chondral knee lesions. Recently an autologous tissue engineered cartilage (Hyalograft C), using biodegradable scaffolds for cell proliferation, was successfully developed. In osteochondritis dissecans (OCD) the lesion also involves subchondral bone. For this reason we began to use a two-step technique: arthroscopic autologous bone grafting followed by autologouos condrocyte Hyalograft C transplantation after 4–6 months. We treated five patients affected by OCD. All the patients were clinically evaluated and analysed according to the International Repair Cartilage Society score at 12 and 24 months. The ICRS score showed highly satisfactory clinical results in all treated patients at 12 and 24 months; CT and MRI evaluation had demonstrated a good articular surface reconstruction with complete bone defect restoration at a short 12-month follow-up period. The autologous chondrocyte transplantation provides highly satisfactory clinical results. This second-generation autologous tissue-engineered cartilage transplantation avoids the use of periosteal flap, simplifies the surgical procedure and permits use of an arthroscopic approach. In association with autologous bone grafting, bone loss can also be restored in order to recreate a perfect articular surface. The preliminary clinical and histological results are encouraging but longer follow-up is required to better evaluate this technique

Purpose of the study: Autologous chondrocyte transplantation has become in the last years more and more popular for the treatment of chondral knee lesion. The standard procedure has good result, however important disadvantages represent the difficulty to manage liquid chondrocyte culture solution and the necessity to create the hermatic periosteum suture.The aim of the our study was to investigate the short time results of a matrix-induced chondrocyte transplantation (MACT) for treatment cartilage defects in the knee und to analyse ad- or disadvantages. Method: Since June 2001 we use for the autologous chondrocyte transplantation (ACT) instead of a periosteum flap the 3-dimensional matrix or resorbarble fleece. 35 patients with defects in cartilage of the knee have been treated so far. Average defect size was 4,8 qcm, all patients had a follow up with clinical investigations and MRI studies. The results were evaluated by different scores. Results: 33 of 35 patients were after six months satisfied with the operation result or justed it more better. All of the subjective or objektive parameters of the different scores were improved after one year. The clinical outcome was good in the follow-up. Conclusion: In the follow up the results can be compared with the one found in literature of the standard periost method. The matrix-induced chondrocyte transplantation has the advantage, that no periost flap is needed and that the chondrocyte culture is not liqiud. The first results are promising

Introduction: Transplantation of autologous chondrocites offers promising results. A new technique is now gaining ground which uses a “scaffolding” of hyaluronic acid (Hyalograft C©, Fidia, Italy). Materials and methods: Thirty-five patients have been treated with Hyalograft C© since 2000. 31 were operated on for a knee and 4 for an ankle. Clinical progression was documented both preoperatively and postoperatively by means of a clinical protocol (VAS-Scale, Lysholm, ICRS, IKDC; AOFAS, Cincinnati). Twenty-one patients with knee lesions (11 had particular circumscribed defects, 7 had complex lesions and/or related lesions, 3 patients were given this indication as a last resort in an effort to avoid the use of a prosthesis) and 4 with ankle lesions were followed up for over 6 months postop. Results: Assessment by means of the VAS-Scale showed a reduction in pain. In addition, it was possible to show an improvement in function ranging from 51 points pre-op to 75 points post-op on the Lysholm Score. In patients with particular lesions an improvement of 57 to 97 points was achieved. All of the 3 patients where the indication was used as a last resort received a prosthesis. In ankles, the improvement ranged between 2,5 to 6.3 points on the modified Cincinnati-Score. Conclusions: In the case of the classical indication for isolated femoral defects, the results obtained with Hyalograft C© show similar results to I.C.A. In complex lesions, results were considerably worse. Osteoarthritis has shown itself not to be an indication for this technique. On the other hand, the use of Hyalograft C© makes it possible to perform transplants with a smaller surgical incision as well as to fill defects without resorting to sutures

Today several therapeutic options exist for the management of early degenerative lesions in the knee. These include marrow stimulation techniques (abrasion arthroplasty, sub-chondral drilling, microfracturing), periosteal and perichondral graft interposition, the implantation of synthetic matrices (collagen, carbon fibres, or glycosaminoglycan gel), autologous chondrocyte transplantation, osteochondral mosaic autografts or allografts, or simple arthroscopic lavage and debridement. It appears that some of these techniques are moderately successful in the short-term, especially in younger patients with relatively recent localised chondral lesions or erosion, and in joints with normal stability and alignment. In these optimal conditions, it is possible to achieve repair in 70% of the diseased area. However, the cartilage remains substandard, with a one-third decrease in stiffness and increased tissue permeability. In the early degenerative knee, conservative treatment options include unloader bracing and the use of chondroprotective agents. Unloader braces have been shown to improve the disease-specific quality of life and the functional status of patients with varus osteoarthritis in prospective randomised clinical trials. However, patients often find braces uncomfortable and of doubtful effectiveness. Current information about the use of chondroprotective agents in the treatment of osteoarthritis suggests that intra-articular hyaluronic acid improves lubrication in the joint and helps to decrease swelling and inflammation. Used as dietary supplements, oral glucosamine and chondroitin sulphate appear to work synergistically together to cause a net increase in the amount of healthy articular cartilage, hereby slowing the progression of osteoarthritis. Convenient and safe, these intra-articular and oral chondroprotective agents present an exciting new approach in the treatment of early degenerative knee lesions

There is quite a high incidence of musculoskeletal disorders in the hemophiliac patients because of their insufficiency in blood coagulation. Knee joint disability is the most troublesome problem among the all. Repeated bruise and intra-articular hemorrhage may activate hypertrophic synovitis and progress to advanced arthritis. The characteristic clinical presentation is their fusiform limbs with moderate degree of contracture and deformity. Treatments include administration of specific coagulation factors, aspiration of hemarthrosis and proper bracing. Synovectomy will treat and retard the progression of the disease, while some advanced cases may end up to spontaneous fusion or need surgical arthrodesis. Total knee arthroplasty is another option for such a knee problem in hemophiliac patients. We have done 26 total knee arthroplasties in 19 hemophiliac patients since 1986. Male is predominant with sex-linked inheritance with only one exception. The timing for them to have surgery is from 22 to 47 years old with mean age of 30. Gross patholgies of the knee lesion are quite universal as hypertrophy of hemosiderin deposited synovium, destruction of articular catilage, subchondral bone loss, marginal osteophytes formation, fibrous contracture around the joints. Two cases were excluded for other systemic disease. With the help of supplementary coagulation factor, the surgical courses were rather smooth with one exception of septic shock episode. There were no infections in total series but three revisions of prosthesis were done because of loosening or malposition. All the patients were satisfied with the improvement of function score and range of knee motion. Total knee arthroplasty did a great success for the relief of pain and function for such a knee disorder. The only remained troublesome problem is the extremely high cost of the coagulation factor therapy which may be an economic shock to the patients

Autologous chondrocyte transplantation has become a possible solution for the treatment of chondral knee lesions. In the last years matrix autologous chondrocyte transplantation procedures were developed by various scientists. We selected a biodegradable, hyaluronian-based biocompatible scaffold for cell proliferation. This nonwoven three-dimensional structure consists of a network of 20 – B5-thick fibers with interstices of variable sizes which constitute an optimal physical support to allow cell-cell contacts, cluster formation, and extracellular matrix deposition in order to create a bioengenerized cartilage Hyalograft C. The easy handling of Hyalograft C in open surgery has suggested us to investigate its possible use by an arthroscopic procedure. Arthroscopic technique has been used from December 2000 in 88 cases. At December 2003 45 patients achieved at least 1 year follow up and 22 patients – 2 years follow up. All the patients were clinically evaluated was analyzed according to the International Repair Cartilage Society score at 12 and 24 months. Returning back to sport was also recorded. We were able to obtain CT scans or MRI images for all patients at 6, 12 and 24 months of follow up. No complications related to the implant and no serious adverse events were observed during the treatment and follow up period. The IKDC objective score improved after 12 months in all patients, showing a normal or nearly normal knee in 96,7% of patients. The mean IKDC subjective score obtained was 41,3 at baseline, 76.9 at the 12 months follow-up control, and 75,9 after 24 months. The worsening of IKDC score was noted in 1 of 22 patients analyzed at 12 and 24 months follow up. A second look arthroscopy was performed in 11 patients at 12 months follow up and a complete healing of the defect and the excellent quality of regenerated cartilage was noted at macroscopic examination. The histological evaluation in 6 cases has demonstrated the hyaline type of new cartilage, although not completely mature. This matrix autologous chondrocyte transplantation procedure avoids the use of periosteal flap, simplify the surgical procedure and permit to perform the arthroscopic implant. Thus, complications as hypertrophy or ossification of periosteal flap are avoided and the surgical morbidity and the recovery time for the patient are extremely reduced. The preliminary clinical and histological results are encouraging but the decree absolute on the efficiency of this method will be assessed at longer follow up

Introduction. Ceramic total knee arthroplasty (TKA) was introduced as a new-generation of knee prostheses in clinical practice, and are expected to reduce polyethylene wear due to its resistance to abrasion and lubrication. In 1992, we developed a cruciate retaining LFA-I total knee prosthesis (KYOCERA Medical Co., Japan), which comprises an alumina ceramic femoral component and a titanium-alloy tibial component with a polyethylene insert. The purpose of this study was to evaluate clinical results in rheumatoid patients who were treated with the alumina-ceramic LFA-I prosthesis with a minimum 15-year follow-up period. Methods. A total of 70 primary TKAs were performed in 51 patients between 1993 and 1996 using the cemented alumina-ceramic LFA-I prosthesis. Sixteen of these patients (20 knees) had died by the time of this study, of causes unrelated to the index arthroplasty, and 11 patients (16 knees) were lost to the follow-up. The remaining 34 knees were clinically and radiographically evaluated in the present study. The average follow-up time was 16.7 years. The average age of the patients was 58.2 years at the time of the operation. The clinical assessment was conducted with the Hospital for Special Surgery Knee rating score and the Knee Society scoring system. The component alignment and bone-implant interface were evaluated according to the Knee Society Roentgenographic Evaluation System. Results. The cumulative survival rate for revision for any reason at 15 years was 94.1%. The mean postoperative range of motion was 115.3 degrees at the time of the most recent follow-up. The mean postoperative knee score was 90.1 and 84.7 using the Knee Society and the Hospital for Special Surgery rating systems, respectively. Reoperations had been required on two knees due to loosening and on one knee due to infection. Periprosthetic radiolucencies or osteolysis were present in six knees. All lesions occurred around the prosthetic rim; 3 lesions at the anterior femoral flange, 5 lesions at the medial tibia, 2 lesions at the lateral tibia, and 1 lesion at the anterior tibia. These implants did not migrate, subside, or have circumferential radiolucencies that would indicate radiographic loosening. Discussion. In this series of patients with rheumatoid arthritis, the alumina-ceramic LFA-I prosthesis has performed well for the average 16.7 years of follow-up. It is not possible to draw any conclusions regarding the superiority of the ceramic prosthesis with respect to wear and survivability, however, the lack of a ceramic breakage with this anatomical design has encouraged us to continue to use this ceramic prostheses

Purpose: Characterized chondrocyte implantation (CCI) uses an autologous cartilage cell population capable of making stable cartilage in vivo. Despite comparable short-term improvement after intervention, clinical follow-up was to determine long-term clinical benefit of CCI in the repair of full-thickness knee cartilage lesions. Methods: In a randomized controlled clinical trial comparing CCI to microfracture, patients with single ICRS grade III/IV symptomatic defects of the femoral condyles were randomized to receive either treatment (n=57 vs. n=61, respectively). Clinical improvement was measured up to 36 months using the KOOS, Visual Analogue Scale for knee pain (VAS) and Activity Rating Scale (ARS). Treatment failures and safety were monitored throughout. Results: At baseline, KOOS was comparable between treatment groups (Mean ± SD: CCI, 56.30 ± 13.61; microfracture, 59.53 ± 14.95); improvement from baseline in adjusted mean ± SE of the overall KOOS at 36 months was 21.25 ± 3.60 for the CCI group and 15.83 ± 3.48 for the microfracture group. In a mixed linear model (with LOCF imputation), significantly greater improvements were shown for CCI vs. microfracture in change from baseline in all KOOS domains (p-value for the Overall KOOS = 0.0007) except for ‘Sports’. Between-group improvements from baseline to month 36 in VAS and ARS scores were similar. For CCI and micro-fracture groups, the percentages of treatment responders (improvement of 10 percentage points or more) were 83% (n = 34 of 41) vs. 62% (n = 31 of 50) on the KOOS and 83% vs. 66% on the VAS. Time to treatment failure was not statistically significant between the groups (n CCI/MF = 7/9). There was no change in safety profiles in comparison to the previous recorded data. Conclusions: The initial superior structural outcome with CCI after 12 months post-surgery was substantiated by superior clinical benefit at 36 months compared to microfracture

Tissue engineering in the treatment of cartilage lesions utilises chondrocytes or mesenchymal stem cells (MSCs) seeded on tridimensional scaffolds. These methods are associated with high costs and two surgical procedures. Aim of this study was to evaluate the healing process of osteochondral lesions treated by drilling (in order to permit the migration of MSCs) and collagen membrane implant (to facilitate cell proliferation and differentiation). Bilateral ostechondral lesions of the knee were induced in 24 sheep: two lesions 5 mm in diameter at the femoral condyle and two at the throclear groove in each knee. The lesions were treated as follows: drilling and typeI/II collagen membrane implant. Control lesions were treated by drilling alone. Macroscopic, histoimmunohistochemical and histomorphometric analyses were performed at 1, 6 and 12 months after operation. The treated lesions were repaired with a hyaline-like tissue at 12 months, in comparison to control lesions which showed incomplete filling with fibrous tissue. The use of collagen membranes covering articular defects avoids cell dispersion and maintains the necessary tissue permeability. Chondrocytes or MSCs seeded on these membranes proliferate and express differentiated phenotypes. The present study showed in an experimental model that drilling and collagen membrane implant represents a surgical approach to osteochondral lesions which produces a hyaline-like scar tissue

Lesions to articular cartilage have a poor capability of regeneration and by mechanical wear and enzymatic digestion they may progress to osteoarthritis. In Sweden more than 900 patients with chondral or osteochondral lesions have been treated with autologous chondrocyte transplantation (ACT) since 1987. Cartilage is harvested arthroscopically and the chondrocytes are isolated. After two weeks of culturing the chondrocytes are deposited in the cartilage lesion in a cell suspension. The chondrocytes start to produce matrix and gradually form new hyaline cartilage able to withstand the forces of the knee. Lesions to the femoral condyles have shown the most promising results when treated with ACT (90% Good/Excellent, n=57), osteochonditis dissecans showed 84% Good/Excellent results (n=32), multiple knee joint lesions 75% Good/Excellent (n=53) and femoral condyle lesions with anterior cruciate ligament reconstruction 74% Good/Excellent (n=−27) at a long term follow up (2–11 years). The outcome after patella lesions treated with ACT were initially not as good (2 of 7 patients were graded Good or Excellent at a mean follow-up of 36 months) but better understanding of the nature of patellar lesions and development of the surgical technique have improved the result (65% Good or Excellent, n=32). Patients treated with ACT for cartilage lesion to the femoral trochlea showed Good/Excellent results in 58% (n=12). At a second look arthroscopy biopsies were taken in 37 patients. In 80% of the biopsies the repair tissue was classified as hyaline like cartilage. Immunohistochemical analysis of collagen II, aggrecan and comp showed ++ to +++ for the hyaline like repair tissue compared to +++ for normal cartilage. There were also a strong correlation (0.73) between hyaline like repair and Good/ Excellent results. Other areas have been transplanted as well such as the tibial plateau, the talus and the head of the humerus, but due to the small numbers of patients and short follow-up ACT to these areas is not yet recommended. The clinical outcome after treating chondral and osteochondral lesions in the knee is good at a long term follow-up and the repair tissue is histological similar to normal articular cartilage

Objectives

Matrix-assisted autologous chondrocyte transplantation (MACT) has been developed and applied in the clinical practice in the last decade to overcome most of the disadvantages of the first generation procedures. The purpose of this systematic review is to document and analyse the available literature on the results of MACT in the treatment of chondral and osteochondral lesions of the knee.